Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
9.06M
-
Shares change
-
+512K
-
Total reported value, excl. options
-
$42.6M
-
Value change
-
+$2.51M
-
Number of buys
-
23
-
Number of sells
-
-7
-
Price
-
$4.70
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2020
35 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q4 2020.
Summit Therapeutics Inc. - COM (SMMT) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.06M shares
.
Largest 10 shareholders include Polar Capital Holdings Plc (5.8M shares), BlackRock Inc. (731K shares), VANGUARD GROUP INC (549K shares), JPMORGAN CHASE & CO (494K shares), BAILLIE GIFFORD & CO (372K shares), MORGAN STANLEY (254K shares), RENAISSANCE TECHNOLOGIES LLC (253K shares), ExodusPoint Capital Management, LP (186K shares), UBS Group AG (138K shares), and WELLS FARGO & COMPANY/MN (45K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.